Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9581779rdf:typepubmed:Citationlld:pubmed
pubmed-article:9581779lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:9581779lifeskim:mentionsumls-concept:C0237401lld:lifeskim
pubmed-article:9581779lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:9581779lifeskim:mentionsumls-concept:C0282552lld:lifeskim
pubmed-article:9581779lifeskim:mentionsumls-concept:C1332700lld:lifeskim
pubmed-article:9581779lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:9581779lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9581779lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:9581779lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:9581779lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:9581779lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:9581779lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:9581779lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:9581779pubmed:issue1lld:pubmed
pubmed-article:9581779pubmed:dateCreated1998-5-22lld:pubmed
pubmed-article:9581779pubmed:abstractTextWe examined the human immunodeficiency virus type 1 infectability of CD4+ lymphocytes isolated from CCR5 wild-type individuals, individuals heterozygous for the delta32 allele of CCR5, and HIV-1-exposed but uninfected (EU) individuals who had CD4+ lymphocytes refractory to M-tropic viral replication. None of the EU individuals were found to be heterozygous for the delta32 allele. The CD4+ lymphocytes isolated from CCR5/delta32 and EU individuals were less infectable with an M-tropic viral isolate of HIV-1 than CCR5/CCR5 control individuals but were equally as infectable with a T-tropic viral isolate. The restriction to M-tropic viral isolate replication did not associate with any profound genotypic change in the CCR5 gene. CD4+ lymphocytes from CCR5/delta32 and CCR5/CCR5 EU individuals were more sensitive to the HIV-inhibitory effects of the recombinant beta-chemokines RANTES, MIP-1alpha, and MIP-1beta than were CD4+ lymphocytes from CCR5/CCR5 control individuals. CD4+ lymphocytes from EU individuals also showed increased sensitivity to recombinant beta-chemokines and low surface expression of CCR5. A phenotype of low CCR5 expression and high secretion of beta-chemokines is associated with reduced infectability of cells by M-tropic HIV-1. This phenotype may also be associated with protection against sexual transmission of HIV-1.lld:pubmed
pubmed-article:9581779pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9581779pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9581779pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9581779pubmed:languageenglld:pubmed
pubmed-article:9581779pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9581779pubmed:citationSubsetIMlld:pubmed
pubmed-article:9581779pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9581779pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9581779pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9581779pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9581779pubmed:statusMEDLINElld:pubmed
pubmed-article:9581779pubmed:monthAprlld:pubmed
pubmed-article:9581779pubmed:issn0042-6822lld:pubmed
pubmed-article:9581779pubmed:authorpubmed-author:KanoKKlld:pubmed
pubmed-article:9581779pubmed:authorpubmed-author:LidMMlld:pubmed
pubmed-article:9581779pubmed:authorpubmed-author:WuLLlld:pubmed
pubmed-article:9581779pubmed:authorpubmed-author:GingerasT RTRlld:pubmed
pubmed-article:9581779pubmed:authorpubmed-author:LandauN RNRlld:pubmed
pubmed-article:9581779pubmed:authorpubmed-author:MackayC RCRlld:pubmed
pubmed-article:9581779pubmed:authorpubmed-author:KoupR ARAlld:pubmed
pubmed-article:9581779pubmed:authorpubmed-author:PaxtonW AWAlld:pubmed
pubmed-article:9581779pubmed:issnTypePrintlld:pubmed
pubmed-article:9581779pubmed:day25lld:pubmed
pubmed-article:9581779pubmed:volume244lld:pubmed
pubmed-article:9581779pubmed:ownerNLMlld:pubmed
pubmed-article:9581779pubmed:authorsCompleteYlld:pubmed
pubmed-article:9581779pubmed:pagination66-73lld:pubmed
pubmed-article:9581779pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9581779pubmed:meshHeadingpubmed-meshheading:9581779-...lld:pubmed
pubmed-article:9581779pubmed:meshHeadingpubmed-meshheading:9581779-...lld:pubmed
pubmed-article:9581779pubmed:meshHeadingpubmed-meshheading:9581779-...lld:pubmed
pubmed-article:9581779pubmed:meshHeadingpubmed-meshheading:9581779-...lld:pubmed
pubmed-article:9581779pubmed:meshHeadingpubmed-meshheading:9581779-...lld:pubmed
pubmed-article:9581779pubmed:meshHeadingpubmed-meshheading:9581779-...lld:pubmed
pubmed-article:9581779pubmed:meshHeadingpubmed-meshheading:9581779-...lld:pubmed
pubmed-article:9581779pubmed:meshHeadingpubmed-meshheading:9581779-...lld:pubmed
pubmed-article:9581779pubmed:meshHeadingpubmed-meshheading:9581779-...lld:pubmed
pubmed-article:9581779pubmed:meshHeadingpubmed-meshheading:9581779-...lld:pubmed
pubmed-article:9581779pubmed:meshHeadingpubmed-meshheading:9581779-...lld:pubmed
pubmed-article:9581779pubmed:year1998lld:pubmed
pubmed-article:9581779pubmed:articleTitleReduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.lld:pubmed
pubmed-article:9581779pubmed:affiliationAaron Diamond AIDS Research Center, The Rockefeller University, New York, New York 10016, USA.lld:pubmed
pubmed-article:9581779pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9581779pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9581779pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9581779lld:pubmed